Why Aurinia Pharmaceuticals Stock Crashed in After-Hours Trading on Friday

Motley Fool2021-11-21

What happened Shares of Aurinia Pharmaceuticals (NASDAQ:AUPH) fell by 18.1% in after-hours trading Friday. The drugmaker's stock tanked in response to a $250 million mixed shelf offering. The ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

JorgenS
2021-11-22
JorgenS
Ouch
KFChen
2021-11-22
KFChen
Woa
Sunny0809
2021-11-22
Sunny0809
Ok
koolgal
2021-11-22
koolgal
With no buyout in sight, investors are bailing out of Aurinia. But is it a good time to bargain hunt? I prefer to hedge my bets with$Health Care Select Sector SPDR Fund(XLV)$ which includes all the big guns of pharma and more. 👍😊
- koolgal:
  Glad you agree. Thanks
- WJ2:
  Agree. ETFs are usually safest bet
- koolgal:
  Thanks
- koolgal:
  Thanks
- koolgal:
  My pleasure
Haw75
2021-11-22
Haw75
Latest
Weeckee
2021-11-22
Weeckee
Business decision.

发表看法

984

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2184828149?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-11-21 11:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2184828149","market":"us","top_or_hot":-1,"title":"Why Aurinia Pharmaceuticals Stock Crashed in After-Hours Trading on Friday","media":"Motley Fool","content":"<div>\n<p>What happened\nShares of Aurinia Pharmaceuticals (NASDAQ:AUPH) fell by 18.1% in after-hours trading Friday. The drugmaker's stock tanked in response to a $250 million mixed shelf offering.\nThe ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/20/why-aurinia-pharmaceuticals-stock-crashed-in-after/\">网页链接</a>\n\n</div>\n","source":"fool_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Aurinia Pharmaceuticals Stock Crashed in After-Hours Trading on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Aurinia Pharmaceuticals Stock Crashed in After-Hours Trading on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-21 11:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/20/why-aurinia-pharmaceuticals-stock-crashed-in-after/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What happened\nShares of Aurinia Pharmaceuticals (NASDAQ:AUPH) fell by 18.1% in after-hours trading Friday. The drugmaker's stock tanked in response to a $250 million mixed shelf offering.\nThe ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/20/why-aurinia-pharmaceuticals-stock-crashed-in-after/\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AUPH","symbol_name":"Aurinia Pharmaceuticals Inc","start_time":0,"source_url":"https://www.fool.com/investing/2021/11/20/why-aurinia-pharmaceuticals-stock-crashed-in-after/","article_id":"2184828149","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2184828149","pubTimestamp":1637463859,"sourceInfo":{"source_id":"fool_stock","name":"Motley Fool"},"weMediaInfo":null,"summary":"A $250 mixed shelf offering isn't sitting well with the biotech's shareholders.","collect":0,"end_time":0,"defaultTopTitle":"fool.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"AUPH":"Aurinia Pharmaceuticals Inc","BK4139":"生物科技"},"translate_title":"为什么Aurinia Pharmaceuticals Inc股票在周五盘后交易中暴跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AUPH":0.9},"content_text":"What happened\nShares of Aurinia Pharmaceuticals (NASDAQ:AUPH) fell by 18.1% in after-hours trading Friday. The drugmaker's stock tanked in response to a $250 million mixed shelf offering.\nThe accompanying prospectus filed with the Securities and Exchange Commission noted that the proceeds of any stock sales under this offering would be used for clinical development and commercial production of the company's Food and Drug Administration approved lupus nephritis (LN) medication Lupkynis. It would advance its pipeline, business development opportunities, capital expenditures, and working capital.\nAt the end of the third quarter, Aurinia had a cash runway of approximately six to perhaps eight quarters, depending on the commercial trajectory of Lupkynis, as well as the company's clinical development plans.\nSo what\nShareholders are hitting the exits on this biotech stock for one clear reason: This mixed shelf offering may spell the end of buyout talks. Last month, Aurinia's shares blasted higher on rumors that Bristol Myers Squibb (NYSE:BMY) was contemplating a bid for the company. Soon thereafter, additional rumors surfaced claiming that Aurinia had multiple suitors. To date, however, a formal tender offer has yet to materialize from any party.\nAnd while neither Bristol nor Aurinia have publicly denied these rumors, there are some obvious problems with this hypothetical tie-up. Specifically, Bristol has multiple holes to fill to keep its top line headed in the right direction, and only about $16 billion in cash to achieve this goal. Aurinia, for its part, probably won't accept an offer under $6 billion. What's more, the biotech might be holding out for an offer in excess of $8 billion.\nNow what\nIs Aurinia's stock a screaming buy after this after-hours drop? The answer is most definitely yes. While Lupkynis' sales might be slow to ramp up with Aurinia at the helm, the drug is starting to turn heads among prescribers, according to a recent survey. As such, Aurinia's top line should eventually grow by leaps and bounds. Savvy investors, therefore, shouldn't hesitate to take advantage of this unwarranted pullback in this undervalued biotech stock.","kind":"highlight","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":872297451,"gmtCreate":1637536564388,"gmtModify":1637536564490,"author":{"id":"3556245356712656","authorId":"3556245356712656","name":"JorgenS","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3556245356712656","authorIdStr":"3556245356712656"},"htmlText":"Ouch","listText":"Ouch","text":"Ouch","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/872297451","repostId":2184828149,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":872293247,"gmtCreate":1637535849694,"gmtModify":1637535849930,"author":{"id":"3576990193651421","authorId":"3576990193651421","name":"KFChen","avatar":"https://static.tigerbbs.com/6830fa3fe8a82d29953fbb2e6153801e","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3576990193651421","authorIdStr":"3576990193651421"},"htmlText":"Woa","listText":"Woa","text":"Woa","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/872293247","repostId":2184828149,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":872207574,"gmtCreate":1637535541908,"gmtModify":1637535542001,"author":{"id":"3581539047362830","authorId":"3581539047362830","name":"Sunny0809","avatar":"https://static.tigerbbs.com/3ffb7aab0292fd1f17dfb9f99bc5eb03","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3581539047362830","authorIdStr":"3581539047362830"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/872207574","repostId":2184828149,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":872647619,"gmtCreate":1637529861497,"gmtModify":1637538217617,"author":{"id":"3559581955535845","authorId":"3559581955535845","name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3559581955535845","authorIdStr":"3559581955535845"},"htmlText":"With no buyout in sight, investors are bailing out of Aurinia.&nbsp; But is it a good time to bargain hunt? I prefer to hedge my bets with<a href=\"https://laohu8.com/S/XLV\">$Health Care Select Sector SPDR Fund(XLV)$</a>&nbsp;which includes all the big guns of pharma and more. 👍😊","listText":"With no buyout in sight, investors are bailing out of Aurinia.&nbsp; But is it a good time to bargain hunt? I prefer to hedge my bets with<a href=\"https://laohu8.com/S/XLV\">$Health Care Select Sector SPDR Fund(XLV)$</a>&nbsp;which includes all the big guns of pharma and more. 👍😊","text":"With no buyout in sight, investors are bailing out of Aurinia. But is it a good time to bargain hunt? I prefer to hedge my bets with$Health Care Select Sector SPDR Fund(XLV)$ which includes all the big guns of pharma and more. 👍😊","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":25,"commentSize":12,"repostSize":0,"link":"https://laohu8.com/post/872647619","repostId":2184828149,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6671276,"gmtCreate":1637539655509,"gmtModify":1637539655509,"authorId":3559581955535845,"author":{"id":3559581955535845,"idStr":"3559581955535845","authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":872647619,"type":1,"supId":6670823,"prevId":0,"content":"Glad you agree. Thanks","text":"Glad you agree. Thanks","html":"Glad you agree. Thanks"},{"id":6670823,"gmtCreate":1637538246763,"gmtModify":1637538246797,"authorId":3585096301616437,"author":{"id":3585096301616437,"idStr":"3585096301616437","authorId":3585096301616437,"name":"WJ2","avatar":"https://static.tigerbbs.com/321728f2a96c9249d1e52afe191a5b7e","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":872647619,"type":1,"supId":0,"prevId":0,"content":"Agree. ETFs are usually safest bet","text":"Agree. ETFs are usually safest bet","html":"Agree. ETFs are usually safest bet"},{"id":6670816,"gmtCreate":1637538217572,"gmtModify":1637538217572,"authorId":3559581955535845,"author":{"id":3559581955535845,"idStr":"3559581955535845","authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":872647619,"type":1,"supId":6669788,"prevId":0,"content":"Thanks","text":"Thanks","html":"Thanks"},{"id":6670813,"gmtCreate":1637538209143,"gmtModify":1637538209143,"authorId":3559581955535845,"author":{"id":3559581955535845,"idStr":"3559581955535845","authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":872647619,"type":1,"supId":6669831,"prevId":0,"content":"Thanks","text":"Thanks","html":"Thanks"},{"id":6670810,"gmtCreate":1637538203522,"gmtModify":1637538203522,"authorId":3559581955535845,"author":{"id":3559581955535845,"idStr":"3559581955535845","authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":872647619,"type":1,"supId":6670398,"prevId":0,"content":"My pleasure","text":"My pleasure","html":"My pleasure"}],"langContent":"CN"},{"id":872642204,"gmtCreate":1637524826912,"gmtModify":1637524827084,"author":{"id":"3580379447244817","authorId":"3580379447244817","name":"Haw75","avatar":"https://static.tigerbbs.com/b8a435feb2331b895463eca3c73cdb3f","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3580379447244817","authorIdStr":"3580379447244817"},"htmlText":"Latest&nbsp;","listText":"Latest&nbsp;","text":"Latest","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/872642204","repostId":2184828149,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":872642034,"gmtCreate":1637522300882,"gmtModify":1637522301088,"author":{"id":"3582072953259355","authorId":"3582072953259355","name":"Weeckee","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3582072953259355","authorIdStr":"3582072953259355"},"htmlText":"Business decision.","listText":"Business decision.","text":"Business decision.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/872642034","repostId":2184828149,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":984,"commentSize":55,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2184828149"}